Implementation and Prospects of individualized drug therapy

来源 :2015年第一届药代动力学朝阳论坛 | 被引量 : 0次 | 上传用户:savage10000
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Individualized medicine is to choose the best therapeutic strategy based on patients genotype.With known genotype, it can choose the proper drug and dosage at the proper time for patients, improve drug efficacy, decline side effects, and decrease suffering and cost simultaneously.Human genetic polymorphisms cause individual difference of drug efficacy and toxicity.It also lead to many new drugs are withdrawn from the market because of the serious toxicity in the genetic mutation carriers.Statistical analysis shows that about 1/3 patients can not get satisfactory efficacy in vast majority drugs, almost 1/6 have side effect in different degrees, and the total effective rate is only about 50%.Up to date, adverse reaction is the fifth leading cause.According to development in genomic research, more and more relationships between genotype and drugs are discovered.It means revolution of drug use is approaching.Individualized medicine therapy can direct drug use in clinical, such as which drug should be used, and predict the efficacy, toxicity and prognostic.These are all based on genotypes and information of the drug related genes.For instance, we use the genotype of HER2 gene to determine whether Herceptin is appropriate for the patients.
其他文献
  Human UDP-glucuronosyltransferases (UGTs) are important phase Ⅱ drug-metabolizing enzyme involved in the glucuronidation of drugs, toxicants, and some impo
会议
  狂犬病病(RABV)糖蛋白(G)是病毒中和抗体的主要抗原和动物体中的主要免疫蛋白.通过反向遗传操作技术在HEP-Flury病毒株中编码两个G基因重组成HEP-dG毒株.对HEP-dG株与其
会议
  It is well recognized that the nitrile group in most nitrile-containing drugs is passed through the body unchanged.Nitrile biotransformation is rare and, wh
会议
  In the recent years the more and more innovative drugs have been developed in China.It changes the mode of early phase clinical trials in China.To accommoda
会议
近年我国狂犬病病例数虽呈逐年下降趋势,但年死亡人数仍在千例左右,防控形势依然严峻,同时,病原也呈现出新的种群分布特征.与己控制人狂犬病的国家不同,我国除2013年分离到蝙
会议
2004年~2014年在我国狂犬病高发省份如广东、广西、重庆、云南、上海、山西、浙江、江苏、山东、河南、天津和湖南等,以及具有代表性的省市如青海、陕西、甘肃、新疆和内蒙古
会议
回顾2005年中国开展狂犬病监测以来狂犬病流行、预防控制以及相关政策策略方面的变化和进展,分析其在狂犬病防控过程中的作用和意义.方法汇总分析2005年狂犬病监测以来有关狂
会议